To view this email as a web page, click here

   Home

Subscribe

Advertise

 

 

 

 

September 18, 2018

Today's Rundown

Featured Story

Novo to lay off 400 staff in major R&D reorganization

Novo Nordisk is laying off 400 employees in China and Denmark as part of a reorganization of its R&D department. The reshuffle comes as the company seeks to build a pipeline of chronic disease drugs capable of mitigating the pressures faced by its core diabetes business.

Top Stories

Second former GSK researcher admits stealing trade secrets

Another scientist who previously worked for GlaxoSmithKline has admitted conspiring to steal trade secrets from the company and pass them on to a Chinese rival.

Servier drops GeNeuro’s multiple sclerosis drug after midphase miss

Servier has turned down the chance to license a multiple sclerosis drug from GeNeuro. The decision comes a year after the monoclonal antibody, GNbAC1, failed to beat placebo in a phase 2b trial.

[Sponsored] Six Practices of High Performing Clinical Research Sites

Clinical research sites have a tough, but critically important, job. It’s rigorous and precise work, but essential to the progress of medicine.

Allergan, Sosei halt Alzheimer’s trials amid safety scare

Allergan and Sosei have voluntarily paused development of HTL0018318 after tests in nonhuman primates uncovered unexpected toxicology findings. Phase 1 and 2 clinical trials of the muscarinic M1 receptor agonist are on hold while the partners investigate the toxicology results.

Roivant launches lung-focused Respivant with phase 2 IPF drug

Roivant Sciences’ spinout machine keeps turning, with the launch of the lung-disease focused Respivant Sciences, a company built around an inhaled drug for treating chronic cough in patients with idiopathic pulmonary fibrosis.

Virion Biotherapeutics fills out executive ranks with CEO, CSO

Virion Biotherapeutics announced Monday that Vanessa King and Isabel Najera have signed on as CEO and chief scientific officer, respectively.

Viking Therapeutics’ fatty liver drug cuts cholesterol in phase 2

Viking Therapeutics’ lead lipid disorder asset met its primary and secondary endpoints in a midstage trial, dropping cholesterol and liver fat levels in patients with nonalcoholic fatty liver disease.

BioTime names new CEO amid leadership shuffle

BioTime has appointed Brian Culley to serve as its sole CEO, as part of a corporate restructuring executed by the board of directors. Culley takes over for co-CEOs Adi Mohanty and Michael West, effective immediately.

Genentech antibiotic shows broad activity against multidrug-resistant bugs in mice

Scientists at Genentech have perfected a naturally occurring molecule so it can penetrate E. coli and other Gram-negative bacteria. The discovery could lead to a whole new class of antibiotics.

FierceMedTech Fierce 15 calls for 2018 nominations

This year, we’re hoping to continue spotlighting the most innovative and promising private startups in the medtech industry, and we need your help.

Resources

[eBook] Healthcare and Life Sciences - Data Value Chain

Download our new eBook to learn how Healthcare and Life Sciences organizations are taking advantage of solutions from AWS and the AWS Partner Network to obtain value from critical data.

[Whitepaper] How to Re-Design your Regulatory Capabilities

A top 20 pharma and growing biotech re-engineer regulatory processes.

[Infographic] Flexible. Scalable. Proactive.

Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries.

[Case Study] FSP Insourcing – Relationship Growth Built on Results, Trust

Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries.

[Whitepaper] The Future of Pharmacovigilance: Leveraging Technology and Automation

Are automation, big data and artificial intelligence (AI) a key part of your company’s pharmacovigilance strategy? Read this whitepaper to know what they should be!

[eBook] 2018 Weekly Compendium

The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry.

[Whitepaper] Choosing the Best Sterile Dosage Form for Your Phase I Clinical Supply Needs

When developing a parenteral, pharmaceutical scientists are faced with a variety of choices – choices that can be conflicting or present differing advantages.

[Whitepaper] Scale-Up and Technical Transfer for Lyophilized Products

Baxter BioPharma Solutions’ whitepaper offers a method to address the challenges of tech transfer for lyophilized products from lab-scale to commercial-scale.

[Whitepaper] Addressing the Special Commercial Challenges in Rare Diseases

A whitepaper outlining the key commercial challenges facing rare disease products, and how biopharmaceutical companies can overcome them.

[Webinar] Enabling precision medicine with Tableau and AWS

Inova is using the capabilities of Tableau on AWS to identify biomarkers for personalized treatment intended to improve health outcomes for children.

[Webinar] Build a holistic data management strategy for Life Sciences

Reltio and IQVIA provide holistic data management solutions for traditional pharma, emerging biotech, and consumer health companies, on AWS.

[Webinar] Safeguard your Life Sciences data with Druva and AWS

Life Sciences organizations are embracing cloud-based Master Data Management (MDM) to modernize the organization of critical data.

[Whitepaper] Evolving Approaches to Drug Value Assessment in Global Markets

The window of market exclusivity continues to narrow dramatically in the global marketplace. Given this demanding environment, your global market access team faces increasing urgency to get the value proposition right at the time of launch.

[Whitepaper] HOW TO POSITION YOUR PATIENT SUPPORT PROGRAM FOR SUCCESS

When was the last time your patient support program perfectly aligned with the patient journey, solving all the critical gaps in positioning your brand for success? Follow the 3-D approach to your solution design, and you will achieve a better outcome for your patients.

[eLearning] BIOAVAILABILITY 101

Develop a basic understanding of principles and concepts of bioavailability of oral drugs.

Events

.